Ultrahigh field MRI offers opportunities for USPIO enhanced MRI for diagnosing lymph node metastases in prostate cancer, by improving resolution and increasing the sensitivity to USPIO particles. The assessment of lymph nodes based on size, shape and USPIO uptake can improve the differentiation between non-cancer and metastatic lymph nodes and may also lower the detection size limit for metastatic nodes. In this work we show the first results of USPIO enhanced MRI and computed echo time imaging of patients with high risk prostate cancer at 7 Tesla.
This abstract and the presentation materials are available to members only; a login is required.